32 studies found for:    " August 19, 2009":" September 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" August 19, 2009":" September 18, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Enrolling by invitation Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing
Conditions: HIV;   HIV Infections
Interventions: Behavioral: Keep It Up!;   Behavioral: Information only
2 Active, not recruiting Statin Therapy to Improve Atherosclerosis in HIV Patients
Conditions: Cardiovascular Disease;   HIV;   Atherosclerosis;   Inflammation;   Statins, HMG-CoA;   HIV Infections
Interventions: Drug: atorvastatin;   Drug: Placebo
3 Active, not recruiting TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Children and Adolescents
Conditions: HIV Infections;   HIV-1
Intervention: Drug: Etravirine
4 Completed Mentor Mothers: A Sustainable Family Intervention in South African Townships
Conditions: Human Immunodeficiency Virus;   Acquired Immune Deficiency Syndrome;   Tuberculosis
Intervention: Behavioral: Peer support and mentoring
5 Completed Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects
Conditions: HIV;   HIV Infections
Interventions: Drug: maraviroc;   Drug: control group
6 Recruiting Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia;   Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   B-cell Adult Acute Lymphoblastic Leukemia;   B-cell Childhood Acute Lymphoblastic Leukemia;   B-cell Chronic Lymphocytic Leukemia;   Blastic Phase Chronic Myelogenous Leukemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Burkitt Lymphoma;   Childhood Chronic Myelogenous Leukemia;   Childhood Diffuse Large Cell Lymphoma;   Childhood Immunoblastic Large Cell Lymphoma;   Childhood Myelodysplastic Syndromes;   Childhood Nasal Type Extranodal NK/T-cell Lymphoma;   Chronic Myelomonocytic Leukemia;   Chronic Phase Chronic Myelogenous Leukemia;   Cutaneous B-cell Non-Hodgkin Lymphoma;   de Novo Myelodysplastic Syndromes;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV Infection;   HIV-associated Hodgkin Lymphoma;   Intraocular Lymphoma;   Juvenile Myelomonocytic Leukemia;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Previously Treated Myelodysplastic Syndromes;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Childhood Anaplastic Large Cell Lymphoma;   Recurrent Childhood Grade III Lymphomatoid Granulomatosis;   Recurrent Childhood Large Cell Lymphoma;   Recurrent Childhood Lymphoblastic Lymphoma;   Recurrent Childhood Small Noncleaved Cell Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Chronic Lymphocytic Leukemia;   Refractory Hairy Cell Leukemia;   Relapsing Chronic Myelogenous Leukemia;   Secondary Myelodysplastic Syndromes;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   T-cell Adult Acute Lymphoblastic Leukemia;   T-cell Childhood Acute Lymphoblastic Leukemia;   T-cell Large Granular Lymphocyte Leukemia;   Testicular Lymphoma;   Waldenström Macroglobulinemia
Interventions: Procedure: leukapheresis;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Other: laboratory biomarker analysis
7 Unknown  HIV-discordant Couple Intrauterine Insemination
Conditions: Infertility;   HIV Infections
Interventions: Other: Sperm washing and testing for HIV contamination;   Procedure: Intrauterine Insemination
8 Completed HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children
Conditions: Malaria;   HIV Infections
Interventions: Drug: LPV/r + 2 NRTIs;   Drug: NVP or EFV + 2 NRTIs
9 Completed Trial Embedded in an Electronic Personal Medical Health Records
Conditions: HIV Infections;   Health Literacy
Interventions: Other: Online access to a personal health record;   Other: No access to the PHR
10 Completed A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa
Condition: HIV Infections
Interventions: Drug: FTC/TDF;   Drug: Placebo
11 Completed CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment Regimes
Conditions: Acquired Immunodeficiency Syndrome;   HIV Infections
Interventions: Drug: Lopinavir/Ritonavir plus Lamivudine/Zidovudine;   Drug: Efavirenz plus Lamivudine/Zidovudine
12 Unknown  The Effect of Combination of Traditional Chinese Medicine (TCM) and Highly Active Antiretroviral Therapy (HAART) on Immune Reconstitution of HIV/AIDS Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 3;   Drug: Fuzheng 1;   Drug: Placebo
13 Unknown  Research on Effect of Traditional Chinese Medicine (TCM) on Immune Reconstitution of HIV/AIDS Patients After Highly Active Antiretroviral Therapy (HAART)
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 2;   Drug: Placebo
14 Unknown  Clinical Trials on the Effect of Immunity 1 (Fuzheng 1) on Immune Reconstitution of HIV Patients
Conditions: Acquired Immune Deficiency Syndrome Virus;   HIV Infections
Interventions: Drug: Fuzheng 1;   Drug: Placebo
15 Completed Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
Conditions: Malaria in Pregnancy;   HIV Infections
Interventions: Drug: cotrimoxazole;   Drug: mefloquine
16 Completed Infant Male Circumcision in Gaborone, Botswana, and Surrounding Areas: Feasibility, Safety and Acceptability
Conditions: HIV Infections;   Circumcision
Interventions: Procedure: Circumcision;   Device: Mogen Clamp;   Device: Plastibell;   Device: AccuCirc
17 Unknown  Reducing HIV Risks in African American Teens
Condition: HIV Infections
Intervention: Behavioral: Healthy Futures parent education
18 Active, not recruiting Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected Patients
Conditions: HIV Infections;   Lipoatrophy
Interventions: Drug: EFV;   Drug: LPV/r
19 Completed Optimal Time to Start Antiretroviral Therapy in HIV-infected Adults With Cryptococcal Meningitis
Conditions: Cryptococcal Meningitis;   HIV Infections
Intervention: Other: Early antiretroviral therapy
20 Completed Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients
Conditions: HIV Infections;   Neisseria Gonorrhoeae;   Chlamydia Trachomatis;   Herpes Simplex
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-32) Show next page of results
Indicates status has not been verified in more than two years